Local treatment with tumor necrosis factor alpha in a patient with lung cancer

Tumor Necrosis Factor alfa (TNFa) is a cytokine with cytolytic and cytotoxic properties. First clinical trials in which TNF was administered parenterally date back to early 70-ties. Soon it was noticed that when administered strictly to the tumor mass TNF exhibits high anti-tumor efficacy, exemplifi...

Full description

Saved in:
Bibliographic Details
Published inPolski merkuriusz lekarski Vol. 2; no. 12; p. 382
Main Authors Chciałowski, A, Płusa, T, Szczylik, C, Mamełka, B, Bajera, I, Targowski, T, Dudko, S, Wcisło, G
Format Journal Article
LanguagePolish
Published Poland 01.06.1997
Subjects
Adult
Chemotherapy, Cancer, Regional Perfusion
Female
Humans
Lung Neoplasms - drug therapy
Remission Induction
Tumor Necrosis Factor-alpha - administration & dosage
Online AccessGet more information

Cover

More Information
Summary:Tumor Necrosis Factor alfa (TNFa) is a cytokine with cytolytic and cytotoxic properties. First clinical trials in which TNF was administered parenterally date back to early 70-ties. Soon it was noticed that when administered strictly to the tumor mass TNF exhibits high anti-tumor efficacy, exemplified by total or at least substantial regression of the tumor mass while producing minor and controllable symptoms. In this paper the case of local administration of the recombinant TNFa directly into the tumor mass constricting the bronchus was presented.
ISSN:1426-9686